The research has been transformational in helping us understand the critical touch points in the patient pathway at 1L treatment and beyond – finding barriers to identifying eligible DLBCL patients that could otherwise be missed.
This project has been the cornerstone of some pivotal decisions in our planning and actions for the year.
Jamina Gibson
Associate Director, Product Management – Gilead Sciences Ltd
We are super proud that this work with Gilead Sciences was shortlisted for the Best Customer Insight Award at the 2025 BHBIA BOBI Awards!
By engaging cross-functional stakeholders, building on existing knowledge and employing a bespoke research methodology, we elevated Gilead’s customer understanding and provided tangible recommendations that have been transformational in powering Gilead’s UK brand planning, communication and selling strategy in 2024 and beyond.
Executive Summary
Vision
To drive the continued success of CAR T through a deep understanding of customers’ behaviours, beliefs and experiences
Approach
An immersive two-step research plan consisting of patient record forms and extended interviews; key to the success of this project was the cross functional engagement from kick off to delivery, rooted in Gilead’s key business questions.
Impact
A pivotal piece of research, transformational in providing a deeper understanding of critical customer touchpoints.
A foundation for Gilead’s 2024 strategy, directly informing brand planning, messaging updates and the selling strategy. Which in turn has increased earlier patient identification.
Learn more about our Health and Pharma expertise here.
